Francesco Di Gennaro, Giacomo Guido, Luisa Frallonardo, Francesco Vladimiro Segala, Rosalba De Nola, Gianluca Raffaello Damiani, Elda De Vita, Valentina Totaro, Mario Barbagallo, Emanuele Nicastri, Antonella Vimercati, Ettore Cicinelli, Giuseppina Liuzzi, Nicola Veronese, Annalisa Saracino
BACKGROUND: Clinical evidence suggests that pregnant women are more vulnerable to COVID-19, since they are at increased risk for disease progression and for obstetric complications, such as premature labor, miscarriage, preeclampsia, cesarean delivery, fetal growth restriction and perinatal death. Despite this evidence, pregnant women are often excluded from clinical trials, resulting in limited knowledge on COVID-19 management. The aim of this systematic review and meta-analysis is to provide better evidence on the efficacy and safety of available COVID-19 treatment in pregnant women...
November 9, 2023: BMC Infectious Diseases